Researchers at the Abramson Cancer Center at the University of Pennsylvania have found a way to identify lung cancer at the cellular level in real time during a biopsy, offering promise in the ability to detect the disease earlier and with more confidence. The research is published this week in Nature Communications.
A novel method produces a new class of radioactive tracers that are used for medical imaging. The method allows them to attach radioactive atoms to compounds that have previously been difficult or even impossible to label. The advance will make it easier to track medications in the body and identify tumors and other diseases.